| Literature DB >> 35441950 |
Anna Maráz1, Zoltán Kovács2, Eric Benjamins3, Melinda Pázmándi4,2.
Abstract
Galacto-oligosaccharides (GOS) are used as prebiotic ingredients in various food and pharmaceutical formulations. Currently, production of GOS involves the enzymatic conversion of lactose by transgalactosylation using β-galactosidase. The purity of the resulting product is low, typically limited to up to 55% GOS on total carbohydrate basis due to the presence of non-reacted lactose, and the formation of by-products glucose and galactose. In industrial practice high-purity GOS is manufactured by removing the unwanted mono- and disaccharides from raw GOS with simulated moving bed (SMB) chromatography. This purification step is associated with high processing cost that increases the price of pure GOS and limits its marketability. The last decades have witnessed a growing interest in developing competitive biotechnological processes that could replace chromatography. This paper presents a comprehensive review on the recent advancements of microbial GOS purification, a process commonly referred to as selective fermentation or selective metabolism. Purification strategies include: (i) removal of glucose alone or together with galactose by lactose negative yeast species, that typically results in purity values below 60% due to remaining lactose; (ii) removal of both mono- and disaccharides by combining the fast monosaccharide metabolizing capacity of some yeast species with efficient lactose consumption by certain lactose positive microbes, reaching GOS purity in the range of 60-95%; and (iii) the application of selected strains of Kluyveromyces species with high lactose metabolizing activity to achieve high-purity GOS that is practically free from lactose and monosaccharides.Entities:
Keywords: Fermentation strategies; Galacto-oligosaccharides (GOS); Microbial purification; Prebiotics
Mesh:
Substances:
Year: 2022 PMID: 35441950 PMCID: PMC9021073 DOI: 10.1007/s11274-022-03279-4
Source DB: PubMed Journal: World J Microbiol Biotechnol ISSN: 0959-3993 Impact factor: 4.253
Fig. 1Current advances of GOS purification via selective metabolism of non-GOS sugars by key microorganisms. End products of purification represent the main types of commercial GOS
Types of crude GOS purification with various microbes, characteristics of the applied fermentation processes and final purity achieved at the end of fermentation
| Categorya | Microorganismb | Crude GOS (w/w%) | Fermentation conditionsc | Type of sugar depletiond | Nutrient supplemente | Fermentation time (hours) | GOS purityf (%) | References |
|---|---|---|---|---|---|---|---|---|
| A/ | 45 | Batch | B | NA | 32 | 57 | Goulas et al. ( | |
| 20 | Batch, IC | B | NA | 4 | 37 | Li et al. ( | ||
| 16.7 | Batch | B | NA | 10 | 49 | Hernández et al. ( | ||
| – | SSP | B | NA | 24 | 40 | Aburto et al. ( | ||
| – | SSP | B | NA | 8 | 25.7 | Aburto et al. ( | ||
| 15 | Batch | C | 5 g/L YE | 24 | 49 | Pázmándi et al. ( | ||
| B/ | 10 | Batch | B | NA | 70 | > 95 | Giacomelli et al. ( | |
| – | SSP | B | NA | 60 | > 85 | Saravanan et al. ( | ||
| 20 | Batch | B | NA | 32 | 65 | Srivastava and Mishra ( | ||
| 10 | Batch | C | 5 g/L YE | 72 | 92 | Pázmándi et al. ( | ||
| C/ | 20 | Batch | C | 5 g/LYE | 30 | 98 | Cheng et al. ( | |
| 20 | Batch, IC | B | NA | 18 | 97 | Li et al. ( | ||
| 20 | Batch | B | NA | 48 | 100 | Guerrero et al. ( | ||
| 10 | Batch | B | NA | 15 | > 95 | Sun et al. ( | ||
| 30 | Batch, IC | C | 3 g/L YE + inorg N, S, P | 26 | 100 | Tokošová et al. ( | ||
| 20 | Batch | B | NA | 19 | 96 | Santibáñez et al. (2016) | ||
| 10 | Batch | C | 5 g/L YE | 72 | 92 | Pázmándi et al. ( | ||
| 10 | Batch | C | 5 g/L YE | 72 | 100 | Pázmándi et al. ( | ||
| 10 | Batch | B | NA | 8 | 75 | Zheng et al. (2021) |
aA/: fermentation with lactose negative microbes B/: combination of lactose negative and positive microbes C/: fermentation with lactose positive microbes
bAbbreviation of the genus names: K.: Kluyveromyces, S.: Saccharomyces, Sm.: Sporobolomyces, Sc.: Streptococcus, C.: Cyberlindnera
cIC: immobilized cells; SSP: Simultaneous synthesis and purification
dB: Bioconversion, C: Catabolism
eYE: Yeast extract; NA: Not applicable
fGOS purity: ratio of the ΣDP3-DP6 fractions and total amount of carbohydrates at the end of the fermentation